Cancer
Spot malignant transformation and map the tumor microenvironment from molecular spatial structure, not morphology alone.
AlphaTissue reads spatial transcriptomics and spatial proteomics together to predict how tissue goes wrong — cancer, inflammation, senescence — straight from the measured tissue.
Spot malignant transformation and map the tumor microenvironment from molecular spatial structure, not morphology alone.
Find where inflammation and immune infiltration are happening, and tell resolving states from chronic ones.
Pick out senescent cells and their neighborhoods in situ. There's no single marker for senescence — which is exactly why more than one modality helps.
An NIH Common Fund program building open molecular and spatial maps of the healthy human body, across many organs, donors and assay types.
An NIH Common Fund program mapping senescent cells across tissues and lifespan — the data you need to study senescence where it actually sits.
Built on open data. AlphaTissue uses publicly released data from the HuBMAP and SenNet consortia.